151 filings
424B5
KZR
Kezar Life Sciences Inc
22 Mar 24
Prospectus supplement for primary offering
4:05pm
S-8
KZR
Kezar Life Sciences Inc
14 Mar 24
Registration of securities for employees
4:33pm
10-K
2023 FY
KZR
Kezar Life Sciences Inc
Annual report
14 Mar 24
4:15pm
8-K
KZR
Kezar Life Sciences Inc
14 Mar 24
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
4:04pm
8-K
KZR
Kezar Life Sciences Inc
8 Jan 24
Results of Operations and Financial Condition
8:36am
8-K
hrxgl4mfo sa
4 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:28pm
8-K
yt8sz76xt03hfd
13 Nov 23
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
w1nog265osx pvp
27 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
n2v9h
3 Oct 23
Cash runway extended to fund PALIZADE global Phase 2b clinical trial evaluating zetomipzomib in lupus nephritis; topline data expected mid-2026
4:14pm
8-K
aqbisi4hl8ax 1897
20 Sep 23
Entry into a Material Definitive Agreement
6:40pm
8-K
bk0ypzocevo0
11 Aug 23
Other Events
5:52pm
8-K
r6p bve0740xfaz4
10 Aug 23
Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
88nwz5l6
26 Jul 23
Departure of Directors or Certain Officers
4:37pm
8-K
zm4c3
16 Jun 23
Material Modifications to Rights of Security Holders
4:07pm
S-8
zc032s2b0q 8q
11 May 23
Registration of securities for employees
4:34pm
8-K
kitax dq7
11 May 23
Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
4:04pm
EFFECT
8oomaxfx4wis
8 May 23
Notice of effectiveness
12:15am